Tag: Lake Stockholm Project

BioLargo's Q3 2025 report shows tech traction in PFAS, Clyra™, and Cellinity™ — but monetization remains elusive post-Pooph® fallout.

BioLargo's Q2 exposes value-chain gaps—regulatory lags, partner dependency, and no clear path from validation to revenue.

BioLargo’s growth hinges on its AEC, Clyra™, and Pooph® innovations, but delays and cash burn turn Q2–Q3 into a critical test for its long-term ambitions.

BioLargo CEO Dennis P. Calvert appointed to the U.S. Environmental Technologies Trade Advisory Committee as company celebrates 80% revenue growth in 2024.

BioLargo, Inc. starts its Lake Stockholm PFAS removal pilot this month with its efficient AEC technology, reducing hazardous waste by over 99% compared to GAC.